Clinical Trial Update: A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating GSK5458514 alone or in combination with other anti-cancer agents in prostate cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• GSK5458514

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Prostate | Phase 1, Phase 2 | Status: RECRUITING